NIH VideoCast - Mutant p53 Activities in Mouse Tumor Models

Skip Navigation

Mutant p53 Activities in Mouse Tumor Models

Loading... Loading video...

302 Views

Air date:	Wednesday, December 7, 2022, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 302 (108 Live, 194 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:09:52
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director’s Wednesday Afternoon Lecture Series Margaret Pittman Lecture This is the annual WALS–Pittman lecture, but rescheduled from March 2022. Guillermina (Gigi) Lozano is a renowned geneticist recognized for her studies of the p53 tumor suppressor pathway. This pathway is undermined in a large percent of human cancers via mutations and deletions of p53. Her laboratory identified a transcriptional activation function for p53. Using mouse models, her team characterized the physiological importance of Mdm2 and Mdm4 proteins as potent inhibitors of p53. The Mdm proteins are over expressed in many cancers that lack p53 mutations presenting an alternate mechanism of eliminating p53 activity. Other mouse models inheriting the most common p53 mutations revealed gain-of-function phenotypes that drive metastases. Mutation of the p53 gene is a critical event in the elaboration of many tumors of diverse origin. The p53 protein is activated in response to DNA damage, serving as a checkpoint in the elimination or repair of cells with damaged DNA. Alterations in components of the p53 pathway, such as amplification of the Mdm2 gene, which encodes a p53 inhibitor, also contribute to tumorigenesis. The overall goal of my laboratory is to understand the signals that regulate the p53 pathway and the consequences of expressing wild-type or mutant p53. For more information go to https://oir.nih.gov/wals

NLM Title:	Mutant p53 activities in mouse tumor models / Guillermina Lozano.
Author:	Lozano, Guillermina. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): NIH Director"s Wednesday Afternoon Lecture Series Margaret Pittman Lecture This is the annual WALS-Pittman lecture, but rescheduled from March 2022. Guillermina (Gigi) Lozano is a renowned geneticist recognized for her studies of the p53 tumor suppressor pathway. This pathway is undermined in a large percent of human cancers via mutations and deletions of p53. Her laboratory identified a transcriptional activation function for p53. Using mouse models, her team characterized the physiological importance of Mdm2 and Mdm4 proteins as potent inhibitors of p53. The Mdm proteins are over expressed in many cancers that lack p53 mutations presenting an alternate mechanism of eliminating p53 activity. Other mouse models inheriting the most common p53 mutations revealed gain-of-function phenotypes that drive metastases. Mutation of the p53 gene is a critical event in the elaboration of many tumors of diverse origin. The p53 protein is activated in response to DNA damage, serving as a checkpoint in the elimination or repair of cells with damaged DNA. Alterations in components of the p53 pathway, such as amplification of the Mdm2 gene, which encodes a p53 inhibitor, also contribute to tumorigenesis. The overall goal of my laboratory is to understand the signals that regulate the p53 pathway and the consequences of expressing wild-type or mutant p53. For more information go to https://oir.nih.gov/wals.
Subjects:	Disease Models, Animal Mice Proto-Oncogene Proteins c-mdm2 Transcription Factors Tumor Suppressor Protein p53--genetics
Publication Types:	Lecture Webcast

NLM Classification:	QU 55.2
NLM ID:	9918573277006676
CIT Live ID:	46003
Permanent link:	https://videocast.nih.gov/watch=46003

Related Videos...